This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
HK$2,963
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
Abiomed (ABMD) - P/B ratio
P/B ratio as of March 2025 : 11.2
According to Abiomed's latest financial reports the company has a price-to-book ratio of 15.9955.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Abiomed - P/B ratio (from 2013 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 11.2 | -2.16% |
| 2021-12-31 | 11.4 | -1.81% |
| 2020-12-31 | 11.6 | 57.99% |
| 2019-12-31 | 7.35 | -57.26% |
| 2018-12-31 | 17.2 | 31.28% |
| 2017-12-31 | 13.1 | 11.87% |
| 2016-12-31 | 11.7 | 5.62% |
| 2015-12-31 | 11.1 | 38.8% |
| 2014-12-31 | 7.99 | 20.54% |
| 2013-12-31 | 6.63 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 1.51 | -86.47% | 🇺🇸 USA |
 | 6.93 | -37.90% | 🇺🇸 USA |
 | 3.70 | -66.88% | 🇺🇸 USA |